Blu Pharmaceuticals Opens Puerto Rico Plant
04/14/2010
"The stars aligned for us in Puerto Rico," said Bill Luster, president of Blu Pharmaceuticals. "We were able to acquire a state-of-the-art manufacturing facility for pennies on the dollar of what it would have cost for us to build an operation from the ground up, plus we were able to tap into a highly talented work force."
The Economic Development Bank for Puerto Rico and Small Business Administration extended $10 million in financing to purchase the facility and equipment. The Puerto Rico Industrial Development Company also offered economic incentives to attract Blu.
"In today's tough financing environment, it made a big difference that the Puerto Rican government was willing to partner with us to help finance the project," Luster said.
Blu Caribe will produce seven different drugs, including ciprofloxacin, an anthrax antidote. It also plans to open a research and development segment. Blu supplies generic drugs to wholesalers, group purchasing organizations, mail order pharmacies, and government agencies including the Veteran's Administration, Bureau of Prisons, Indian Health Services, and the Department of Defense.
Most Read
-
-
Trends in Office and Industrial Parks
Q4 2020
-
The Future of the Workforce Is a “Better Normal”
Workforce Q4 2020
-
Another Look at Rural Economies
Q4 2020
-
Supply Chain Execs Respond as Pandemic Creates E-Commerce Surge
Q4 2020
-
Recruiting and Retaining Today’s Manufacturing Workforce
Workforce Q4 2020
-
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
Q4 2019